Cargando…
Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study
The relationship between circulating total bilirubin and incident non-alcoholic fatty liver disease (NAFLD) is uncertain. We aimed to assess the association of total bilirubin with the risk of new-onset NAFLD and investigate any causal relevance to the association using a Mendelian randomization (MR...
Autores principales: | Kunutsor, Setor K., Frysz, Monika, Verweij, Niek, Kieneker, Lyanne M., Bakker, Stephan J. L., Dullaart, Robin P. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125247/ https://www.ncbi.nlm.nih.gov/pubmed/31773475 http://dx.doi.org/10.1007/s10654-019-00589-0 |
Ejemplares similares
-
Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach
por: Kunutsor, Setor K., et al.
Publicado: (2017) -
Self‐Reported Smoking, Urine Cotinine, and Risk of Cardiovascular Disease: Findings From the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) Prospective Cohort Study
por: Kunutsor, Setor K., et al.
Publicado: (2018) -
Soluble Vascular Cell Adhesion Molecules May be Protective of Future Cardiovascular Disease Risk: Findings from the PREVEND Prospective Cohort Study
por: Kunutsor, Setor K., et al.
Publicado: (2017) -
HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study
por: Sokooti, Sara, et al.
Publicado: (2021) -
Urinary albumin excretion and cancer risk: the PREVEND cohort study
por: Luo, Li, et al.
Publicado: (2023)